Comparison of the Effectiveness of the Ultrasound Guided Injections in Patients With Shoulder Impingement Syndrome

Phase 4

Completed

• Conditions: Ultrasound Guided Injection; Shoulder Impingement
• Interventions: Drug: bupivacaine and methylprednisolone

• Registration Number: NCT05015322
• Lead Sponsor: Bursa Yüksek İhtisas Education and Research Hospital

Brief Summary

Shoulder pain, which is the third most common cause of musculoskeletal pain, has different etiologies. Muscle, bone structures and connective tissue pathologies can cause shoulder pain. Impingement syndrome (IS), which can cover many terms such as rotator cuff disorders, tendinitis and tears, is one of the most common pathologies of shoulder pain.

Detailed Description

The hypothesis of this study was that injection types including ACJ would increase treatment efficacy.Therefore, this study investigated the six-month follow-up results of patients undergoing SA injection and SSNB and those receiving SA and ACJ injection.

Study Timeline

• Study Start: 2017-01-01
• Primary Completion: 2021-01-01
• Study Completion: 2021-01-01
• Status Verified: 2021-08
• Study First Submitted: 2021-08-18
• Study First Submitted QC: 2021-08-19
• Last Update Submitted: 2021-08-19
• Study First Posted: 2021-08-20
• Last Update Posted: 2021-08-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

• patients aged 18-65,
• who were suffering from shoulder pain for more than three months and
• who were diagnosed with IS.
• All patients included in the study were diagnosed with IS using Shoulder Magnetic Resonance imaging.

Exclusion Criteria

• the presence of cervical radiculopathy;
• undergoing shoulder operation before;
• the presence of central nervous system or
• the presence of rheumatological disease, and polyneuropathy;
• receiving physical therapy in the shoulder area with a diagnosis of IS within the last six months; and
• receiving any injection therapy in the past.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
subacromial injection	bupivacaine and methylprednisolone	ultrasound (US)-guided subacromial injection
acromioclavicular joint and subacromial injection	bupivacaine and methylprednisolone	ultrasound (US)-guided acromioclavicular joint and subacromial injection
suprascapular nerve block	bupivacaine and methylprednisolone	ultrasound (US)-guided suprascapular nerve block

Primary Outcome Measures

Name	Time	Method
Visual Analogue Scale (VAS)	six month	for pain. 0: no pain at all, 10: worst pain imaginable

Secondary Outcome Measures

Name	Time	Method
Shoulder pain and disability index (SPADI)	six month	This scale was developed to measure pain and disability associated with shoulder pain. It consists of two parts evaluating pain and disability.
Short-Form 12 (SF-12)	six month	The SF-12 has a physical (SF12-PCS) and mental (SF12-MCS) state assessment scale